On Apr. 6, 2020, Sema4 announced that it is now performing rapid molecular testing for the detection of SARS-CoV-2, the coronavirus responsible for COVID-19. Sema4 is partnering with the state of Connecticut and regional healthcare providers to address the pressing need for high-throughput testing, including regular screening of medical personnel and other high-risk populations. Sema4 can analyze 6,000 COVID-19 tests per week and return results within 24-48 hours.